EVALUATION OF SERUM NITRIC OXIDE AS A DIAGNOSTIC AND PROGNOSTIC MARKER IN PATIENTS WITH HEPATOCELLULAR CARCINOMA STARTING LOCO–REGIONAL THERAPY - Current Issue - IJAR